Clinical trials
Diabetes Mellitus, Type 2 trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
230 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 10 |
| 2006 | 8 |
| 2007 | 17 |
| 2008 | 27 |
| 2009 | 16 |
| 2010 | 17 |
| 2011 | 8 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 13 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 197 |
| Recruiting | 11 |
| Terminated | 11 |
| Active, not recruiting | 10 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 79 |
| Novo Nordisk A/S | 46 |
| AstraZeneca | 25 |
| Hoffmann-La Roche | 12 |
| Janssen Research & Development, LLC | 7 |
| Sanofi | 6 |
| Takeda | 6 |
| Boehringer Ingelheim | 5 |
| Bristol-Myers Squibb | 4 |
| GlaxoSmithKline | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 230 |
| Diabetes Mellitus | 66 |
| Obesity | 20 |
| Overweight | 14 |
| Glucose Metabolism Disorders | 13 |
| Metabolic Diseases | 10 |
| Endocrine System Diseases | 9 |
| Renal Insufficiency, Chronic | 9 |
| Hyperglycemia | 8 |
| Cardiovascular Diseases | 7 |
Trials
Showing 26 to 50 of 230. Each trial links to its page on Pharma Observatory.
130 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.